SEC Form 4 · accession 0001185185-15-000130
AV Therapeutics, Inc. · AVTH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Abraham Mittelman
Officer — CEO and CFO · Director · 10% Owner
Period of report
Jan 20, 2015
Accepted (ET)
Jan 21, 2015 · 3:52 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001537293
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 20, 2015 | J | 1,200,000 | — | A | 17,509,079 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The shares reported herein were issued for accrued compensation in accordance with the Reporting Person's consulting agreement with the Issuer.